ZURA Zura Bio
- 3.380
- -0.350-9.38%
- 3.380
- 0.0000.00%
Zura Bio News
POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
8-K: Current report
8-K: Current report
424B3: Prospectus
EFFECT: Others
8-K: Current report
424B7: Prospectus
8-K: Current report
S-1: General form for registration of securities under the Securities Act of 1933
4: Statement of changes in beneficial ownership of securities-Director Ploos van Amstel Arnout
10-Q/A: Quarterly report (Amendment)
8-K: Zura Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights
10-Q: Quarterly report
D: Filing D
SC 13G: Statement of acquisition of beneficial ownership by individuals-RA Capital Management, L.P.(5.1%),Peter Kolchinsky(5.1%), etc.
SC 13G: Statement of acquisition of beneficial ownership by individuals-Venrock Healthcare Capital Partners III, L.P.(9.99%),VHCP Co-Investment Holdings III, LLC(9.99%), etc.
4: Statement of changes in beneficial ownership of securities-Officer Howell Michael
4: Statement of changes in beneficial ownership of securities-Officer Nistala Kiran
4: Statement of changes in beneficial ownership of securities-Director Munshi Amit
4: Statement of changes in beneficial ownership of securities-Director Sidhu Someit
Analysis
Price Target
No Data
